Clinical Trial Update: Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology [Phase 1]

View source ↗

Summary

A Phase 1 trial testing Verdiperstat in patients with semantic dementia due to TDP-43 pathology is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Semantic Dementia
• Semantic Variant Primary Progressive Aphasia

Drugs mentioned

• Verdiperstat (verdiperstat)

Snippet

Sponsor: Peter Ljubenkov, MD | Conditions: Semantic Dementia | Phase 1 | Status: RECRUITING